NASDAQ$MEDP

Medpace Holdings Inc. · Q1 2021 earnings

Q1 2021 earnings · · Investor relations

Briefing

Reported first quarter results with revenue increase and net new business awards.

Medpace Holdings, Inc. announced financial results for the first quarter ended March 31, 2021. Revenue increased by 12.6% to $260.0 million compared to the prior-year period. Net new business awards were $356.2 million, and GAAP net income was $43.3 million, or $1.14 per diluted share.

  • Revenue for the first quarter of 2021 increased 12.6% to $260.0 million.
  • Net new business awards were $356.2 million in the first quarter of 2021, representing an increase of 44.2% from the comparable prior-year period.
  • First quarter of 2021 GAAP net income was $43.3 million, or $1.14 per diluted share.
  • EBITDA was $53.6 million for the first quarter of 2021, an increase of 32.1% from the comparable prior-year period.

Headline financials

Total Revenue

$260M

Previous: $231M+12.6%
EPS (adj)

$1.14

Previous: $0.76+50.0%
Net New Business Awards

$356M

Previous: $247M+44.3%
Capital Expenditures

-$6.51M

Previous: -$5.56M-17.0%
Free Cash Flow

$36.8M

Previous: $23.4M+57.3%
Net Income

$43.3M

Previous: $29M+49.6%
Operating Income

$47.6M

Previous: $35.5M+34.1%
Gross Profit

-$182M

Previous: -$166M-9.5%
Cash & Equivalents

$333M

Previous: $134M+148.4%
Total Assets

$1.45B

Previous: $1.14B+27.6%
Stock-Based Comp

$2.87M

Previous: $5.45M-47.3%

Revenue & EPS history

Medpace · Revenue · Quarterly

$260M

Q1 2021+12.6%vs Q1 2020
Beat estimate in 14 of 16 quarters(88%)
ActualEstimate

Forward guidance

The Company forecasts 2021 revenue in the range of $1.090 billion to $1.150 billion. GAAP net income for full year 2021 is forecasted in the range of $160.6 million to $167.6 million. Additionally, full year 2021 EBITDA is expected in the range of $205.0 million to $215.0 million.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2021

Historical avgQ1 2021

-1.7%

Avg return

Earnings day

-1.6%

Avg return

5 days after

+1.1%

Avg return

30 days after

44%

19 / 43 earnings

Positive

+39.0%

Q3 2022

Best reaction

-31.5%

Q1 2016

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-2.5%-19.4%-14.9%
Q4 2025-15.9%-19.3%-16.3%
Q3 2025+9.0%+6.2%+8.2%
Q2 2025-0.2%+1.5%+7.0%
Q1 2025-2.3%+3.3%+1.4%
Q4 2024-7.5%-4.0%-10.3%
Q3 2024-8.4%-7.3%-8.5%
Q2 2024-15.2%-9.5%-6.1%
Q1 2024+9.4%+6.4%+4.8%
Q4 2023+11.6%+20.0%+25.0%
Q3 2023+18.8%+9.2%+20.8%
Q2 2023+4.6%+3.9%+1.8%
Q1 2023+10.2%+5.9%+7.2%
Q4 2022-2.9%-7.6%-20.4%
Q3 2022+39.0%+41.5%+39.2%
Q2 2022-2.9%+5.0%+3.8%
Q1 2022-12.0%-11.3%-12.2%
Q4 2021-20.6%-18.2%-12.1%
Q3 2021+13.9%+21.1%+14.4%
Q2 2021-6.0%-3.4%-0.8%
Q1 2021-12.8%-11.3%-13.3%
Q4 2020-2.7%-5.3%-2.0%
Q3 2020-6.1%-4.8%+4.4%
Q2 2020+15.5%+12.8%+16.7%
Q1 2020-2.5%-11.9%+9.0%
Q4 2019+2.4%-9.7%-31.7%
Q3 2019+0.8%-0.5%+3.8%
Q2 2019+24.9%+19.9%+27.2%
Q1 2019-4.3%-1.6%-4.7%
Q4 2018-21.3%-21.8%-18.4%
Q3 2018+0.2%+13.9%+21.8%
Q2 2018+28.6%+24.4%+23.4%
Q1 2018+2.3%-0.0%+12.9%
Q4 2017-15.7%-14.3%-5.3%
Q3 2017+6.2%+5.6%-3.7%
Q2 2017+8.0%+15.1%+17.2%
Q1 2016-31.5%-29.1%-12.6%
Q1 2017-29.1%-27.5%-12.3%
Q4 2014-21.3%-20.7%-22.2%
Q2 2016-21.3%-20.7%-22.2%
Q4 2016-19.8%-20.1%-22.3%
Q3 2016+3.8%+8.1%+24.0%
Q4 2015+3.8%+8.1%+24.0%
Q3 2015
Q2 2015
Q1 2015
Q1 2014

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro